ROBERT AMRIEN: Open Payments
NPI 1073570016 · CHELSEA, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 18 payments from 4 companies in 2025. Trend: 2023 $896 · 2024 $372 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $260 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $143 |
| ABBVIE INC. | 1 | $22 |
| Echosens North America, Inc. | 1 | $14 |
Products named: JOURNAVX, AIRSUPRA, BREZTRI, FARXIGA, QULIPTA, Fibroscan.
Industry payments across MA — which companies pay providers there.
